SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $40,000 | -28.6% | 166,000 | -5.1% | 0.00% | – |
| Q1 2018 | $56,000 | -37.1% | 175,000 | 0.0% | 0.00% | – |
| Q4 2017 | $89,000 | -46.1% | 175,000 | -1.1% | 0.00% | -100.0% |
| Q3 2017 | $165,000 | +65.0% | 177,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $100,000 | +49.3% | 177,000 | +65.4% | 0.00% | – |
| Q1 2017 | $67,000 | -18.3% | 107,000 | 0.0% | 0.00% | – |
| Q4 2016 | $82,000 | -13.7% | 107,000 | +92.8% | 0.00% | -100.0% |
| Q3 2016 | $95,000 | +61.0% | 55,500 | +68.2% | 0.00% | – |
| Q2 2016 | $59,000 | -35.9% | 33,000 | -15.4% | 0.00% | -100.0% |
| Q1 2016 | $92,000 | +19.5% | 39,000 | +16.4% | 0.00% | 0.0% |
| Q4 2015 | $77,000 | -8.3% | 33,500 | -9.9% | 0.00% | 0.0% |
| Q3 2015 | $84,000 | -8.7% | 37,200 | +15.5% | 0.00% | 0.0% |
| Q2 2015 | $92,000 | +2200.0% | 32,200 | +1510.0% | 0.00% | – |
| Q1 2015 | $4,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2014 | $4,000 | +100.0% | 2,000 | +100.0% | 0.00% | – |
| Q3 2013 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 13,238,268 | $6,726,000 | 0.58% |
| MSD Partners, L.P. | 4,118,402 | $2,092,000 | 0.11% |
| 683 Capital Management, LLC | 1,500,000 | $762,000 | 0.06% |
| Vivaldi Capital Management LP | 101,145 | $51,000 | 0.04% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,540,000 | 0.02% |
| BARD ASSOCIATES INC | 56,499 | $29,000 | 0.01% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $64,000 | 0.01% |
| Virtu Financial LLC | 299,577 | $152,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 46,981 | $24,000 | 0.01% |
| Stanley-Laman Group, Ltd. | 60,323 | $31,000 | 0.01% |